Management Team

Mark H.N. Corrigan, M.D.

President and Chief Executive Officer

Dr. Corrigan has served as President and Chief Executive Officer Since January 2010. Dr. Corrigan joined U.S.-based specialty pharmaceutical company Sepracor Inc. in 2003 and served as their Executive Vice President, Research & Development until December 2009. Prior to joining Sepracor Inc., Dr. Corrigan spent 10 years with Pharmacia & Upjohn, most recently as Group Vice President of Global Clinical Research and Experimental Medicine. Dr. Corrigan has been a member of the board of directors and the audit committee of Cubist Pharmaceuticals, Inc. since 2008. Prior to joining the pharmaceutical industry, Dr. Corrigan spent five years in academic research at the University of North Carolina Medical School, focusing on psychoneuroendocrinology. Dr. Corrigan holds a B.A. and an M.D. from the University of Virginia and subsequently received specialty training in Psychiatry at Cornell and Maine Medical Center.Back to Top

Christopher C. Gallen, MD, Ph.D.

Executive Vice President of Research and Development

Dr. Gallen has served as Executive Vice President of Research and Development since January 2010. Dr. Gallen served as the President and Chief Executive Officer of Neuromed from July 2004 to December 2009. Prior to joining Neuromed, Dr. Gallen worked for Wyeth Research beginning in April 2002 and most recently served as its Vice President and Chief of Operations, Clinical Research and Development. Prior to Wyeth, Dr. Gallen was VP of Clinical Research at Pharmacia Corporation for three years. From January 1996 to December 1998, Dr. Gallen was the President of the Clinical Research Organization division at Premier Research Worldwide and from 1994 to 1995 he was the Senior Director of Medical and Scientific Services at Quintiles International Clinical Research Corporation. Dr. Gallen holds a B.A. from the University of Florida, and an M.D. and Ph.D. from Emory University School of Medicine in Atlanta, Georgia and trained in Psychiatry at Stanford and Neurology at the University of California, San Diego. Back to Top

Justin Renz

Senior Vice President and Chief Financial Officer

Justin Renz joined CombinatoRx in September 2006 as Vice President, Finance and Treasurer and has served as its Senior Vice President and Chief Financial Officer since July 2009. From August 2005 to September 2006, Mr. Renz was Director, Accounting and Financial Operations at EMD Serono. From 2002 to 2005, he was Senior Director, Global Accounting and Finance at Coley Pharmaceutical Group and has also held financial and accounting positions at ArQule, Inc., Millipore Corporation and Arthur Andersen LLP. Mr. Renz is a certified public accountant and holds a B.A. in Economics/Accounting from the College of the Holy Cross, a Masters in the Science of Taxation from Northeastern University and an MBA from Suffolk University. Back to Top

Terrance Snutch, Ph.D.

Senior Vice President and Chief Scientific Officer

Dr. Snutch has served as Senior Vice President and Chief Scientific Officer since December 2009. Dr. Snutch founded Neuromed in 1995, served as its President from the founding of Neuromed until September 2000, served as its Chief Scientific Officer until March 2002 and its Vice President until December 2009. He has also served as a professor in the Michael Smith Laboratories at the University of British Columbia since January 1989. Dr. Snutch holds a B.Sc. and Ph.D. from Simon Fraser University and carried out postdoctoral studies at the California Institute of Technology. Dr. Snutch received an Honorary Doctorate of Science from Simon Fraser University. Back to Top

C. Eugene Wright, Pharm.D., Ph.D.

Senior Vice President and Chief Development Officer

Dr. Wright has served as Senior Vice President and Chief Development Officer since December 2009. Dr. Wright served as Neuromed’s Vice President, Project Leadership from October 2007 to December 2009. Dr. Wright worked for Schering-Plough Corporation from April 2005 to October 2007 where he most recently served as Executive Director and Senior Project Leader of the Antiviral/Antifungal groups. From October 2003 to April 2005, Dr. Wright was Vice-President of CNS/Pain Development, Project Management and Pharmacokinetics at Biovail Technologies Ltd. From April 2003 to October 2003, Dr. Wright served as Sr. Director, Project Leader at Pfizer Inc. From December 1981 to April 2003, Dr. Wright worked for Pharmacia Corporation, most recently as Senior Director, Project Leader for CNS development. Dr. Wright holds a Doctor of Pharmacy from the University of the Pacific, an M.B.A. from National University in San Diego and a Ph.D. in Pharmaceutical Sciences from the University of Kentucky. Back to Top

Jason F. Cole, Esq.

Senior Vice President, General Counsel and Secretary

Jason F. Cole, Esq. has served as Senior Vice President, General Counsel and Secretary of CombinatoRx since January 2006. From 1999 to 2006, Mr. Cole was a corporate and securities attorney at Ropes & Gray LLP. Mr. Cole holds an A.B. in Government from Dartmouth College and a J.D. from Columbia University School of Law. Back to Top